M. Rogers

The role of sodium channels in neuropathic pain.

E. Stevens, D. Madge, M. Rogers, 2006, Seminars in cell & developmental biology.

Clathrodin, hymenidin and oroidin, and their synthetic analogues as inhibitors of the voltage-gated potassium channels.

J. Tytgat, J. Ilaš, S. Peigneur, 2017, European journal of medicinal chemistry.

Genotype-Phenotpe Correlations in Hypertrophic Cardiomyopathy Insights Provided by Comparisons of Kindreds With Distinct and Identical j3-Myosin Heavy Chain Gene Mutations

S. Colan, J. Triedman, J. Saul, 2005 .

Development of ASIC1a ligand-gated ion channel drug screening assays across multiple automated patch clamp platforms

A. Obergrussberger, Nadine Becker, T. Goetze, 2022, Frontiers in Molecular Neuroscience.

The role of Nav1.7 in human nociceptors: insights from human induced pluripotent stem cell–derived sensory neurons of erythromelalgia patients

A. M. Rush, B. Winner, M. Zenke, 2019, Pain.

A systematic strategy for estimating hERG block potency and its implications in a new cardiac safety paradigm

James Kramer, David G Strauss, Liudmila Polonchuk, 2020, Toxicology and applied pharmacology.

Human Electrophysiological and Pharmacological Properties of XEN-D0101: A Novel Atrial-Selective Kv1.5/IKur Inhibitor

K. Matschke, D. Madge, L. Virág, 2013, Journal of cardiovascular pharmacology.

Characterization of Endogenous Sodium Channels in the ND7-23 Neuroblastoma Cell Line: Implications for Use as a Heterologous Ion Channel Expression System Suitable for Automated Patch Clamp Screening

Nace Zidar, D. Kikelj, M. Rogers, 2016, Assay and drug development technologies.

New aryl and acylsulfonamides as state-dependent inhibitors of Nav1.3 voltage-gated sodium channel.

J. Tytgat, S. Peigneur, T. Tomašič, 2023, European journal of medicinal chemistry.